Evidence map›Paper›PMID 29305446›Full record

ArticleThe bone & joint journal2018

The risk of cardiac failure following metal-on-metal hip arthroplasty.

S A Sabah, J C Moon, S Jenkins-Jones, C Ll Morgan, C J Currie, J M Wilkinson, M Porter, G Captur, J Henckel, N Chaturvedi and 4 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The bone & joint journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

S A SabahRoyal National Orthopaedic Hospital, Stanmore, Middlesex and University College London, London, UK.
J C MoonInstitute of Cardiovascular Sciences, University College London and Barts Heart Centre, London, UK.
S Jenkins-JonesDivision of Surgery and Interventional Sciences, University College London, UK and Global Epidemiology and Medical Statistics, Pharmatelligence, Cardiff, UK.
C Ll MorganDivision of Surgery and Interventional Sciences, University College London, UK and Global Epidemiology and Medical Statistics, Pharmatelligence, Cardiff, UK.
C J CurrieGlobal Epidemiology and Medical Statistics, Pharmatelligence, Cardiff, UK and Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.
J M WilkinsonDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, UK and National Joint Registry for England, Wales and Northern Ireland.
M PorterCentre for Hip Surgery, Wrightington Hospital, Wigan, UK.
G CapturInstitute of Cardiovascular Sciences, University College London, UK and Department of Cardiology, Barts Heart Centre, London, UK.
J HenckelRoyal National Orthopaedic Hospital, Stanmore, UK and Division of Surgery and Interventional Sciences, University College London, UK.
N ChaturvediInstitute of Cardiovascular Sciences, University College London, London, UK.
P KayWrightington Hospital, Wigan, UK.
J A SkinnerRoyal National Orthopaedic Hospital, Stanmore, Middlesex, UK.
A J HartRoyal National Orthopaedic Hospital, Stanmore, Middlesex, UK.
C ManistyInstitute of Cardiovascular Sciences, University College London, UK and Department of Cardiology, Barts Heart Centre, London, UK.

Funding

Medical Research Council MR/P020941/1The Dunhill Medical Trust R363/0514
6 · The paper itself

Abstract

aimsThe aim of this study was to determine whether patients with metal-on-metal (MoM) arthroplasties of the hip have an increased risk of cardiac failure compared with those with alternative types of arthroplasties (non-MoM). PATIENTS AND

methodsA linkage study between the National Joint Registry, Hospital Episodes Statistics and records of the Office for National Statistics on deaths was undertaken. Patients who underwent elective total hip arthroplasty between January 2003 and December 2014 with no past history of cardiac failure were included and stratified as having either a MoM (n = 53 529) or a non-MoM (n = 482 247) arthroplasty. The primary outcome measure was the time to an admission to hospital for cardiac failure or death. Analysis was carried out using data from all patients and from those matched by propensity score.

resultsThe risk of cardiac failure was lower in the MoM cohort compared with the non-MoM cohort (adjusted hazard ratio (aHR) 0.901; 95% confidence interval (CI) 0.853 to 0.953). The risk of cardiac failure was similar following matching (aHR 0.909; 95% CI 0.838 to 0.987) and the findings were consistent in subgroup analysis.

conclusionThe risk of cardiac failure following total hip arthroplasty was not increased in those in whom MoM implants were used, compared with those in whom other types of prostheses were used, in the first seven years after surgery. Cite this article:

Indexed as

AgedAged, 80 and overArthroplasty, Replacement, HipFemaleHeart FailureHip ProsthesisHospitalizationHumansMaleMedical Record LinkageMetal-on-Metal Joint ProsthesesMiddle AgedProsthesis DesignRegistriesRetrospective StudiesRisk FactorsHeart failureHip arthroplastyMetal-on-metalProsthesis

Identifiers

PMID29305446
PMCPMC6424145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.